VEGF

iris eye eyeball eye art
Biotech

Kodiak resurrects eye drug after ph. 3 data renew approval plans

Kodiak Sciences gave up on tarcocimab tedromer earlier this year after a pair of phase 3 failures. A fresh batch of late-stage data has changed that.
James Waldron Nov 6, 2023 8:40am
Moderna manufacturing site

Clean up on IL-2: Moderna mops up autoimmune asset

Aug 3, 2022 10:59am
Yale University campus - red building and a quadrangle with trees

Could a glaucoma drug also fight obesity?

Aug 10, 2018 10:25am